Primary Function of Position:
The Sr Endoluminal Market Development Manager drives market development activities during the pre-
commercialization phase of the Ion Endoluminal System. This role focuses on identifying and building
relationships with key opinion leaders (KOLs) and stakeholders within thoracic surgery and pulmonology, actively
guiding customers from the pre-commercial phase through to full portfolio commercialization. Additionally, the
Manager builds foundational organizational knowledge surrounding this new specialty to support future
innovations. By translating field insights, this leader helps internal departments understand the impact and
resources necessary for a successful launch and sustainable utilization. The ideal candidate must demonstrate
strong, collaborative leadership in a dynamic environment, partnering with global marketing, commercial
leadership, product management, and clinical engineering teams to generate physician and executive interest.
Roles and Responsibilities:
• Prepare the opportunity for Ion product portfolio introduction by establishing relationships with
physicians, hospital executives and specialty specific society leadership
• Build organizational knowledge around the interventional pulmonology, interventional radiology, &
thoracic surgery specialties, with a focus the biopsy and treatment of small peripheral lung lesions:
o Patient journey from 1st visit through treatment
o Various imaging technology and medical devices utilized
o Incentives and barriers within the care pathways
o Identification of key stakeholders throughout evaluation process & financial/clinical value points
• Gain market insights on how lung cancer screening and incidental nodule programs are being implemented
in different hospital segments
• Prepare strategies focused on data that will support the adoption of new technologies
• Understand how ROI is calculated for key financial hospital stakeholders within navigational bronchoscopy
procedures and other competitive modalities
• Interact and communicate on a regular basis with regional and global commercial leadership
• Ability to travel up to 40%